208 related articles for article (PubMed ID: 17517840)
1. Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography.
Li Y; Nguyen MH; Derendorf H; Cheng S; Clancy CJ
Antimicrob Agents Chemother; 2007 Aug; 51(8):2985-7. PubMed ID: 17517840
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.
Clancy CJ; Huang H; Cheng S; Derendorf H; Nguyen MH
Antimicrob Agents Chemother; 2006 Jul; 50(7):2569-72. PubMed ID: 16801448
[TBL] [Abstract][Full Text] [Related]
3. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Samra Z; Yardeni M; Peled N; Bishara J
Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856
[TBL] [Abstract][Full Text] [Related]
4. Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata.
Posteraro B; Martucci R; La Sorda M; Fiori B; Sanglard D; De Carolis E; Florio AR; Fadda G; Sanguinetti M
J Clin Microbiol; 2009 Jun; 47(6):1927-30. PubMed ID: 19403774
[TBL] [Abstract][Full Text] [Related]
5. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Quindós G; Sánchez-Vargas LO; Villar-Vidal M; Eraso E; Alkorta M; Hernández-Almaraz JL
Int J Antimicrob Agents; 2008 Mar; 31(3):266-71. PubMed ID: 18054468
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactions.
Li Y; Nguyen MH; Schmidt S; Zhong L; Derendorf H; Clancy CJ
Int J Antimicrob Agents; 2009 Sep; 34(3):240-5. PubMed ID: 19339162
[TBL] [Abstract][Full Text] [Related]
7. Comparison of posaconazole and voriconazole in vitro killing against Candida krusei.
Cantón E; Pemán J; Valentín A; Bosch M; Espinel-Ingroff A; Gobernado M
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):177-81. PubMed ID: 18691842
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar media.
Pfaller MA; Messer SA; Houston A; Mills K; Bolmstrom A; Jones RN
J Clin Microbiol; 2000 Oct; 38(10):3715-7. PubMed ID: 11015389
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of voriconazole against Candida species isolated in Taiwan.
Yang YL; Cheng HH; Lo HJ
Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436
[TBL] [Abstract][Full Text] [Related]
10. Frequency of voriconazole resistance in vitro among Spanish clinical isolates of Candida spp. According to breakpoints established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing.
Cuenca-Estrella M; Gomez-Lopez A; Cuesta I; Zaragoza O; Mellado E; Rodriguez-Tudela JL;
Antimicrob Agents Chemother; 2011 Apr; 55(4):1794-7. PubMed ID: 21282420
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
Burn AK; Fothergill AW; Kirkpatrick WR; Coco BJ; Patterson TF; McCarthy DI; Rinaldi MG; Redding SW
J Clin Microbiol; 2004 Dec; 42(12):5846-8. PubMed ID: 15583322
[TBL] [Abstract][Full Text] [Related]
13. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
14. Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates.
Oz Y; Kiremitci A; Dag I; Metintas S; Kiraz N
Med Mycol; 2013 Jan; 51(1):60-5. PubMed ID: 22746405
[TBL] [Abstract][Full Text] [Related]
15. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Ng KP; Colombo A; Finquelievich J; Barnes R; Wadula J;
J Clin Microbiol; 2008 Mar; 46(3):842-9. PubMed ID: 18199791
[TBL] [Abstract][Full Text] [Related]
16. Potential fungicidal effect of voriconazole against Candida spp.
Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
[TBL] [Abstract][Full Text] [Related]
17. Emergence of Candida albicans fungemia during voriconazole therapy.
Mohammedi I; Thiebaut A; Piens MA; Argaud L; Martin O; Robert D
J Infect; 2005 Oct; 51(3):e83-4. PubMed ID: 16230209
[No Abstract] [Full Text] [Related]
18. Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.
Magill SS; Shields C; Sears CL; Choti M; Merz WG
J Clin Microbiol; 2006 Feb; 44(2):529-35. PubMed ID: 16455909
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
Pfaller MA; Diekema DJ; Boyken L; Messer SA; Tendolkar S; Hollis RJ
J Clin Microbiol; 2003 May; 41(5):1875-80. PubMed ID: 12734220
[TBL] [Abstract][Full Text] [Related]
20. SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies.
Scorneaux B; Angulo D; Borroto-Esoda K; Ghannoum M; Peel M; Wring S
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
